Belokrylov I V
Zh Nevropatol Psikhiatr Im S S Korsakova. 1986;86(5):749-54.
In order to expand the possibilities of the treatment of resistant hypochondriac schizophrenia, the author developed a new method of multiple modality therapy which is based on the use of the rebound effectiveness of atropine comas. It consists of a course of atropine comatose therapy and a subsequent intensive medicamentous therapy in the form of intravenous instillation of psychotropic agents. This treatment was given to 36 patients with slowly progressive hypochondriac schizophrenia, whose clinical manifestations were restricted to a picture of non-delirious hypochondria. In most cases (82%) the treatment yielded a positive effect. The method was the most effective in patients with syndromes of obsessive and hysterical hypochondria as well as in those with cenesthopathic conditions. The use of therapy in rigid hypochondria proved poorly effective.
为了拓展难治性疑病型精神分裂症的治疗可能性,作者研发了一种新的多模式治疗方法,该方法基于阿托品昏迷的反弹效应。它包括一个疗程的阿托品昏迷治疗以及随后以静脉滴注精神药物形式进行的强化药物治疗。对36例缓慢进展的疑病型精神分裂症患者进行了这种治疗,这些患者的临床表现局限于非谵妄性疑病症状。在大多数病例(82%)中,治疗产生了积极效果。该方法在患有强迫性和癔症性疑病综合征以及存在内感不适状况的患者中最为有效。在僵硬性疑病中使用该疗法效果不佳。